Discussion and consensus points.
- Published in:
- Transplant Infectious Disease, 1999, v. 1, n. s1, p. 40
- By:
- Publication type:
- Article
Works matching IS 13982273 AND DT 1999 AND VI 1 AND IP s1
Results: 9
1
2
Prevention of CMV infection in transplant patients.
- Published in:
- Transplant Infectious Disease, 1999, v. 1, n. s1, p. 35
- By:
- Publication type:
- Article
3
Oral ganciclovir and pharmacokinetics of valganciclovir in liver transplant recipients.
- Published in:
- Transplant Infectious Disease, 1999, v. 1, n. s1, p. 31
- By:
- Publication type:
- Article
4
Role of CMV in transplant coronary artery disease and survival after heart transplantation.
- Published in:
- Transplant Infectious Disease, 1999, v. 1, n. s1, p. 25
- By:
- Publication type:
- Article
5
CMV infection and disease in kidney and pancreas transplant recipients.
- Published in:
- Transplant Infectious Disease, 1999, v. 1, n. s1, p. 19
- By:
- Publication type:
- Article
6
Special considerations regarding CMV in lung transplantation.
- Published in:
- Transplant Infectious Disease, 1999, v. 1, n. s1, p. 13
- By:
- Publication type:
- Article
7
Indirect effects of CMV in the solid organ transplant patient.
- Published in:
- Transplant Infectious Disease, 1999, v. 1, n. s1, p. 8
- By:
- Publication type:
- Article
8
Importance of CMV in the transplant population.
- Published in:
- Transplant Infectious Disease, 1999, v. 1, n. s1, p. 3
- By:
- Publication type:
- Article
9
Cytomegalovirus in the transplant population: current issues and future directions. An introduction to the symposium.
- Published in:
- Transplant Infectious Disease, 1999, v. 1, n. s1, p. 1
- By:
- Publication type:
- Article